Operating cash flow was $406k, including $512k of R&D inflow = an underlying cash out flow.
Disingenous is including an R&D grant in the calculation of "Earnings" and presenting it as EBITDA, and then, using some cunning syntax trying to convey the impression of a 25% EBITDA margin.
That is precisely what NNG did in the most explicit terms possible in black and white and it is totally indefensible.
Spin it all you want.
- Forums
- ASX - By Stock
- NNG
- Ann: NNG Quarterly Activities Report and Appendix 4C Dec-23
Ann: NNG Quarterly Activities Report and Appendix 4C Dec-23, page-12
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NNG (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.046M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
NNG (ASX) Chart |
Day chart unavailable